Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

AstraZeneca PLC (A1ZN34)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
66.66 +0.02    +0.03%
10/05 - Closed. Currency in BRL ( Disclaimer )
Type:  Equity
Market:  Brazil
ISIN:  BRA1ZNBDR003 
  • Volume: 6,722
  • Bid/Ask: 64.84 / 67.50
  • Day's Range: 66.50 - 66.92
AstraZeneca 66.66 +0.02 +0.03%

A1ZN34 Balance Sheet

 
Featured here, the Balance Sheet for AstraZeneca PLC, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 25594 25054 22501 22839
Cash and Short Term Investments 8021 5860 5115 5812
Cash - - - -
Cash & Equivalents 7841 5840 4871 5664
Short Term Investments 180 122 244 148
Total Receivables, Net 12225 11935 11997 11932
Accounts Receivables - Trade, Net 11072 8407 11300 11092
Total Inventory 5337 5424 5292 5051
Prepaid Expenses - 1617 - -
Other Current Assets, Total 11 218 97 44
Total Assets 102293 101119 96086 96543
Property/Plant/Equipment, Total - Net 10616 10502 9700 9624
Property/Plant/Equipment, Total - Gross - 19101 - -
Accumulated Depreciation, Total - -8599 - -
Goodwill, Net 19978 20048 19939 19960
Intangibles, Net 38834 38089 37687 38326
Long Term Investments 1695 1777 1290 1143
Note Receivable - Long Term 1153 3528 697 840
Other Long Term Assets, Total 958 931 912 915
Other Assets, Total -2079 -1555 -2307 -2953
Total Current Liabilities 28901 30542 28588 26375
Accounts Payable 19699 3267 19723 18933
Payable/Accrued - - - -
Accrued Expenses - 15743 - -
Notes Payable/Short Term Debt 1457 5129 515 421
Current Port. of LT Debt/Capital Leases 4966 1260 5994 5254
Other Current liabilities, Total 2779 5143 2356 1767
Total Liabilities 64792 61953 58865 59127
Total Long Term Debt 28271 23260 23044 25119
Long Term Debt 27310 22403 22300 24397
Capital Lease Obligations 961 857 744 722
Deferred Income Tax 2621 2844 2752 2800
Minority Interest 56 23 24 24
Other Liabilities, Total 3331 -2206 -421 50
Total Equity 37501 39166 37221 37416
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 388 388 387 387
Additional Paid-In Capital 35194 35188 35166 35163
Retained Earnings (Accumulated Deficit) -212 4516 -434 -234
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 2131 -926 2102 2100
Total Liabilities & Shareholders' Equity 102293 101119 96086 96543
Total Common Shares Outstanding 1549 1550.16 1549 1550
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

A1ZN34 Comments

Write your thoughts about AstraZeneca PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email